Production of tumour-derived suppressor factor in patients with acute myeloid leukaemia
- 31 December 1991
- journal article
- review article
- Published by Elsevier in Leukemia Research
- Vol. 15 (4) , 263-268
- https://doi.org/10.1016/0145-2126(91)90129-h
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Graft-versus-leukemia reactions after bone marrow transplantationBlood, 1990
- Indomethacin augments lymphokine-activated killer cell generation by patients with malignant mesotheliomaClinical Immunology and Immunopathology, 1989
- In vivo induction of gamma interferon and tumor necrosis factor by interleukin-2 infusion following intensive chemotherapy or autologous marrow transplantationBlood, 1989
- Inhibition of lymphokine-activated killer cell generation by cultured tumor cell lines in vitroCancer Immunology, Immunotherapy, 1989
- Interleukin 2 induction of lymphokine-activated killer (LAK) activity in the peripheral blood and bone marrow of acute leukemia patients. I. Feasibility of LAK generation in adult patients with active disease and in remissionBlood, 1988
- Inhibition of clonogenic growth of fresh leukemia cells by unstimulated and IL-2 stimulated NK cells of normal donorsLeukemia Research, 1987
- PRINCIPAL RESULTS OF THE MEDICAL RESEARCH COUNCIL'S 8th ACUTE MYELOID LEUKAEMIA TRIALThe Lancet, 1986
- Immunotherapy of acute myeloid leukaemia.British Journal of Cancer, 1978